The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma [PDF]
Cells, 2019 The pursuit of matrix metalloproteinase (MMP) inhibitors began in earnest over three decades ago. Initial clinical trials were disappointing, resulting in a negative view of MMPs as therapeutic targets.
Gregg B. Fields
doaj +5 more sources
Bone-Seeking Matrix Metalloproteinase Inhibitors for the Treatment of Skeletal Malignancy [PDF]
Pharmaceuticals, 2020 Matrix metalloproteinases (MMPs) are a family of enzymes involved at different stages of cancer progression and metastasis. We previously identified a novel class of bisphosphonic inhibitors, selective for MMPs crucial for bone remodeling, such as MMP-2.
Antonio Laghezza +11 more
doaj +4 more sources
Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis. [PDF]
PLoS Pathogens, 2018 Mycobacterium tuberculosis (Mtb) remains a grave threat to world health with emerging drug resistant strains. One prominent feature of Mtb infection is the extensive reprogramming of host tissue at the site of infection. Here we report that inhibition of
Yitian Xu +12 more
doaj +3 more sources
Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes. [PDF]
Mol Cancer Ther, 2018 The matrix metalloproteinases (MMP) are a family of proteolytic enzymes that degrade multiple components of the extracellular matrix. A large body of experimental and clinical evidence has implicated MMPs in tumor invasion, neoangiogenesis, and ...
Winer A, Adams S, Mignatti P.
europepmc +2 more sources
Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs) [PDF]
Molecules, 2019 Matrix metalloproteinases (MMPs) are a family of zinc- and calcium-dependent endopeptidases which are secreted or anchored in the cell membrane and are capable of degrading the multiple components of the extracellular matrix (ECM).
Loganathan Rangasamy +6 more
doaj +2 more sources
Discovery and Characterisation of Novel Poly-Histidine-Poly-Glycine Peptides as Matrix Metalloproteinase Inhibitors [PDF]
BiomoleculesFor the first time, two poly-histidine-poly-glycine peptides (pHpG-H5 and pHpG-H7) were identified as promising candidates for matrix metalloproteinase inhibitors. cDNAs encoding pHpG-H5 and pHpG-H7 peptides were isolated from the Atheris squamigera cDNA
He Wang +8 more
doaj +2 more sources
Zymography as a Research Tool in the Study of Matrix Metalloproteinase Inhibitors. [PDF]
Methods Mol Biol, 2017 Matrix metalloproteinases (MMPs) are proteolytic enzymes that degrade various components of the extracellular matrix (ECM) and play a role in tissue remodeling.
Ren Z, Chen J, Khalil RA.
europepmc +2 more sources
Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders. [PDF]
Prog Mol Biol Transl Sci, 2017 Matrix metalloproteinases (MMPs) are zinc-dependent proteolytic enzymes that degrade various proteins in the extracellular matrix (ECM). MMPs may also regulate the activity of membrane receptors and post-receptor signaling mechanisms, and thereby affect ...
Liu J, Khalil RA.
europepmc +2 more sources
Matrix Metalloproteinase Inhibitors and Their Potential Clinical Application in Periodontitis [PDF]
DiseasesMatrix metalloproteinases (MMPs) are a family of endopeptidases recognized for their involvement in the degradation of the extracellular matrix and their important role in the pathogenesis of periodontitis.
Daniela Mendoza-Juárez +5 more
doaj +2 more sources
MMpI: A WideRange of Available Compounds of Matrix Metalloproteinase Inhibitors. [PDF]
PLoS ONE, 2016 Matrix metalloproteinases (MMPs) are a family of zinc-dependent proteinases involved in the regulation of the extracellular signaling and structural matrix environment of cells and tissues.
Charuvaka Muvva +2 more
doaj +2 more sources